Percutaneous Coronary Intervention

Within two decades, MicroPort® has transformed itself from a market follower, into a global leader in the field of Percutaneous Coronary Intervention (PCI). Its proprietary Firehawk® targeted eluting stent system, with proven clinical evidence in terms of safety and efficacy, has become a leading stent, setting industry standards for a new generation of global cardiac stents.

Healthcare Professionals Cardiovascular percutaneous-coronary-intervention

Firehawk®Family

Rapamycin Target Eluting Coronary Stent System

The Firehawk™ family combines a proprietary abluminal groove design, ultra-low drug density, and a bioabsorbable polymer to achieve targeted drug release and support vascular healing.


Both Firehawk™ and Firehawk Liberty™ are supported by the extensive TARGET clinical trial program, demonstrating consistent safety and efficacy.

Firehawk Family
percutaneous-coronary-intervention FIREHAWK 1

Firebird 2

Firebird2 is the first Chinese drug eluting stent with Cobalt-Chromium platform. It has been widely used and recognized both in China and internationally to fulfill the need of treating patients with Coronary Artery Disease.

Firebird2
percutaneous-coronary-intervention Firebird Product 2

PTCA Balloon

Firefighter Firefighter NC Foxtrot Pro Foxtrot NC
percutaneous-coronary-intervention PTCA 3

PCI Accessories

To support PCI interventions, MicroPort® provides a number of accessories.

PCI accessories
percutaneous-coronary-intervention Accessories 4